Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole prophylaxis in AA/hMDS patients undergoing ATG treatment
NCT03318159Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Apr 2018
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of posaconazole in fungal infection, sponsored by Seoul National University Hospital. Started Apr 2018; status: completed.
02
Drugs
posaconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT03318159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318159.